IL198897A - Vaccine against canine application - Google Patents

Vaccine against canine application

Info

Publication number
IL198897A
IL198897A IL198897A IL19889709A IL198897A IL 198897 A IL198897 A IL 198897A IL 198897 A IL198897 A IL 198897A IL 19889709 A IL19889709 A IL 19889709A IL 198897 A IL198897 A IL 198897A
Authority
IL
Israel
Prior art keywords
vector
administration
leishmania
recombinant
sequence
Prior art date
Application number
IL198897A
Other languages
English (en)
Hebrew (he)
Other versions
IL198897A0 (en
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of IL198897A0 publication Critical patent/IL198897A0/en
Publication of IL198897A publication Critical patent/IL198897A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL198897A 2006-11-21 2009-05-21 Vaccine against canine application IL198897A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86684806P 2006-11-21 2006-11-21
PCT/US2007/085142 WO2008064181A2 (en) 2006-11-21 2007-11-19 Prime boost canine leishmania vaccine

Publications (2)

Publication Number Publication Date
IL198897A0 IL198897A0 (en) 2011-08-01
IL198897A true IL198897A (en) 2013-08-29

Family

ID=39430543

Family Applications (1)

Application Number Title Priority Date Filing Date
IL198897A IL198897A (en) 2006-11-21 2009-05-21 Vaccine against canine application

Country Status (11)

Country Link
US (2) US7794736B2 (zh)
EP (1) EP2086580A2 (zh)
AR (1) AR063882A1 (zh)
BR (1) BRPI0719078A2 (zh)
CA (1) CA2670097C (zh)
IL (1) IL198897A (zh)
MA (1) MA31014B1 (zh)
MX (1) MX2009005381A (zh)
TN (1) TN2009000195A1 (zh)
TW (1) TWI478723B (zh)
WO (1) WO2008064181A2 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2283035B1 (en) 2008-05-08 2015-07-29 Merial Limited Leishmania vaccine using sand fly salivary immunogen
US8410258B2 (en) 2008-05-21 2013-04-02 Infections Disease Research Institute Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
ES2528928T3 (es) * 2008-05-21 2015-02-13 Infectious Disease Research Institute Vacunas de poliproteína recombinante para el tratamiento y diagnóstico de leishmaniosis
GB0906906D0 (en) * 2009-04-23 2009-06-03 Univ York Nucleic acid molecule
CN104203271B (zh) 2012-02-14 2017-08-25 梅里亚股份有限公司 表达狂犬病病毒和ox40蛋白的重组痘病毒载体及从其制造的疫苗
WO2016073410A1 (en) 2014-11-03 2016-05-12 Merial, Inc. Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
US10898460B1 (en) 2018-07-20 2021-01-26 University Of South Florida Leishmania inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1615663T3 (da) 2003-10-24 2008-03-31 Mologen Ag Middel til behandling af Leishmania-infektioner
PT1853721E (pt) 2005-02-18 2010-06-08 Astrazeneca Ab Método para determinar a sensibilidade a inibidores de chk1
US7598364B2 (en) * 2005-11-14 2009-10-06 Merial Limited Plasmid encoding canine BMP-7
US8524677B2 (en) * 2006-03-13 2013-09-03 Council Of Scientific And Industrial Research DNA vaccine as immunoprophylaxis against Kala-azar

Also Published As

Publication number Publication date
MX2009005381A (es) 2009-06-30
EP2086580A2 (en) 2009-08-12
WO2008064181A3 (en) 2008-11-20
TWI478723B (zh) 2015-04-01
CA2670097A1 (en) 2008-05-29
MA31014B1 (fr) 2009-12-01
US8871225B2 (en) 2014-10-28
US20080241193A1 (en) 2008-10-02
BRPI0719078A2 (pt) 2013-12-03
CA2670097C (en) 2015-10-06
US20100285066A1 (en) 2010-11-11
IL198897A0 (en) 2011-08-01
US7794736B2 (en) 2010-09-14
TW200826958A (en) 2008-07-01
AR063882A1 (es) 2009-02-25
WO2008064181A2 (en) 2008-05-29
TN2009000195A1 (en) 2010-10-18

Similar Documents

Publication Publication Date Title
AU2013221502B2 (en) Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom
US8871225B2 (en) Canine leishmania vaccine
US10076566B2 (en) Recombinant CDV compositions and uses thereof
CA3000352A1 (en) Canine parvovirus (cpv) virus-like particle (vlp) vaccines and uses thereof
US9228002B2 (en) Leishmania vaccine using sand fly salivary immunogen
US10350287B2 (en) Hendra virus recombinant compositions and uses thereof
AU2015201921A1 (en) Recombinant CDV compositions and uses thereof
AU2012262740A1 (en) Genetic vaccines against Hendra virus and Nipah virus

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed